Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 3/20 | 0.61 |
| ▸ | MPI | P34949 | 1/20 | 0.61 |
| ▸ | PGK1 | P00558 | 1/20 | 0.54 |
| ▸ | PGK2 | P07205 | 1/20 | 0.54 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.40 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16416132 | 1.00 | PGD (0.61) | PGDMPIPGK1PGK2LPAR5 | |
| SCHEMBL428503 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL3515615 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL3748606 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL1403636 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL939456 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL17285 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL1533840 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL20817087 | 0.91 | PGD (0.53) | PGDMPIPGK1PGK2 | |
| SCHEMBL18341413 | 0.89 | PGD (0.67) | PGDMPIPGK1PGK2LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| WO-2018204764-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION (US) | 2018-11-08 | — | — | WO | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |